UMIN ID: UMIN000000572
Registered date:10/01/2007
Efficacy and safety of first-line Vinorelbine single agent in patints with refractory to anthracycline and taxane
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | First-line metastatic breast cancer |
Date of first enrollment | 2006/11/01 |
Target sample size | 40 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | vinorelbine |
Outcome(s)
Primary Outcome | Time to progression |
---|---|
Secondary Outcome | Response rate, toxicity |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | 75years-old |
Gender | Female |
Include criteria | |
Exclude criteria | 1) had another chemotherapy after recurrence 2) having active multiple cancers 3) having serious infenction or severe organ function |
Related Information
Primary Sponsor | Department of Breast and Endocrine surgery, Nagoya University school of medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | none |
Secondary ID(s) |
Contact
public contact | |
Name | Masataka Sawaki |
Address | 65 tsurumai-cho showa-ku Nagoya City Japan |
Telephone | 052-744-2251 |
sawapi@qc4.so-net.ne.jp | |
Affiliation | Nagoya University school of medicine Department of Breast and Endocrine surgery |
scientific contact | |
Name | Tsuneo Imai |
Address | 65 tsurumai-cho showa-ku Nagoya City Japan |
Telephone | 052-744-2251 |
m-sawaki@aichi-cc.jp | |
Affiliation | Nagoya University school of medicine Department of Breast and Endocrine surgery |